lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
289 rows where filing_period = "second_quarter", filing_year = 2011 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1106525 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) e6654942-c001-42f6-8eb2-03b62d0106d6 | Q2 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2011 | second_quarter | MED | all issues relating to pharmaceutical labeling | 25000 | 0 | 0 | 2011-06-14T10:19:32.457000-04:00 | ||
| 1106703 | LAW OFFICES OF MARC SHAPIRO 23f806f6-1779-4fd2-a454-baef7910a4c3 | Q2 | LAW OFFICES OF MARC SHAPIRO | 400761290 | POZEN INC. | 2011 | second_quarter | MED | Amendment of new drug approval provisions of Federal Food, Drug and Cosmetic Act; no bill pending | HOUSE OF REPRESENTATIVES | 20000 | 0 | 0 | 2011-06-27T14:39:20.957000-04:00 | |
| 1107021 | FEDERAL SOLUTIONS, LLC b7d3f4ea-1369-42f0-98e9-0408ad9dbe2f | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2011 | second_quarter | MED | Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-01T10:51:18.630000-04:00 | |
| 1107030 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 62087f79-7a9a-488b-8cad-a8b670102673 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2011 | second_quarter | MED | Appropriations and Authorization legislation for FY 2012 in health care | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2011-07-01T10:57:21.800000-04:00 | |
| 1107075 | FEDERAL SOLUTIONS, LLC 39b5d021-297b-459f-9fd9-aa9187d441ba | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2011 | second_quarter | MED | Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research | Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2011-07-01T11:34:36.597000-04:00 | |
| 1107176 | FRANCIS EDWARD & CRONIN, INC. abc9bd78-50aa-481c-898d-17f17a628bd9 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2011 | second_quarter | MED | Legislation and issues related to Alzheimer's Disease Research | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,Treasury, Dept of,White House Office | 10000 | 0 | 0 | 2011-07-02T16:39:53.077000-04:00 | |
| 1107281 | THE KEELEN GROUP, LLC c7161c62-22e5-4490-8dc3-ecdcf276af18 | Q2 | THE KEELEN GROUP, LLC | 323114 | AMERICAN PHYSICAL THERAPY ASSOCIATION (APTA) | 2011 | second_quarter | MED | Monitored and lobbied upon entire bills of the following: H.R.531, the Access to Frontline Health Care Act of 2011 H.R.1546 / S.829: Medicare Access to Rehabilitation Services Act of 2011; repeal of the Therapy Cap on Outpatient Rehabilitation Services The Medicare Patient Access to Physical Therapists Act (no bill number, formerly H.R.1829 / S.950); to improve access to physical therapists for Medicare beneficiaries | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-05T10:29:19.773000-04:00 | |
| 1107305 | MARSHALL BRACHMAN 4e9576eb-c1fe-4516-8692-af7b5b5be948 | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2011 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2011-07-05T11:22:34.300000-04:00 | |
| 1107320 | MARSHALL BRACHMAN 10914c63-7f1d-4190-b2f6-bf928b011b41 | Q2 | MARSHALL BRACHMAN | 6848 | CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE | 2011 | second_quarter | MED | reverse cardiac catheterization practice expense cuts | HOUSE OF REPRESENTATIVES,SENATE | 12000 | 0 | 0 | 2011-07-05T11:45:45.253000-04:00 | |
| 1107359 | MARSHALL BRACHMAN 60ec3e69-da5f-45bb-ae90-1192ae8d34a2 | 2T | MARSHALL BRACHMAN | 6848 | ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC | 2011 | second_quarter | MED | oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 1 | 2011-07-05T12:19:04.783000-04:00 | |
| 1107529 | GOLDBUG STRATEGIES LLC 762bad91-1dea-4b8a-b88f-4ece55bf0215 | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | COALITION FOR 21ST CENTURY MEDICINE | 2011 | second_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2011-07-05T17:06:26.163000-04:00 | |
| 1107541 | GOLDBUG STRATEGIES LLC 1ec68fca-e33b-45b1-bae0-9acdc2f2795b | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | GENOMIC HEALTH INC. | 2011 | second_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2011-07-05T17:12:29.537000-04:00 | |
| 1107621 | THE CJR GROUP, INC. 081836a4-36cf-41a4-9682-ab711b281e1e | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2011 | second_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-06T10:02:20.763000-04:00 | |
| 1107625 | THE CJR GROUP, INC. d56db4bd-f96e-4c65-831d-c0e1f1104b26 | Q2 | THE CJR GROUP, INC. | 288293 | STERIS CORPORATION | 2011 | second_quarter | MED | Biomedical issues | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-06T10:11:22.560000-04:00 | ||
| 1107827 | MICHAEL SAULS 5fc8a9ca-2b37-41e8-9f53-070ad92e762d | 2T | MICHAEL SAULS | 43638 | MIT HOLDING INC | 2011 | second_quarter | MED | Educating Congress and regulatory agencies about client's products, seeking EPA registration. | Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-07-06T16:10:22.040000-04:00 | ||
| 1108223 | PARRY, ROMANI, DECONCINI & SYMMS 8ad1f7d5-926f-4440-a25c-ba352dd9add0 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2011 | second_quarter | MED | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-07T16:43:07.523000-04:00 | |
| 1108317 | FABIANI & COMPANY a3ce2a77-4dfa-4950-8918-4d3451879865 | 2T | FABIANI & COMPANY | 72576 | SOVA PHARMACEUTICALS, INC. | 2011 | second_quarter | MED | Federal agency interest in and development of pharmaceuticals to treat central sleep apnea. | Army, Dept of (Other),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD) | 0 | 1 | 2011-07-07T18:48:57.287000-04:00 | ||
| 1108631 | COZEN O'CONNOR PUBLIC STRATEGIES 63fffd51-81bc-4792-a9f7-f0bfae4e732e | Q2 | COZEN O'CONNOR PUBLIC STRATEGIES | 400459252 | THOMAS JEFFERSON UNIVERSITY | 2011 | second_quarter | MED | Issues related to grants for medical research development. | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2011-07-08T14:15:35.663000-04:00 | |
| 1108700 | WAKE FOREST UNIVERSITY HEALTH SCIENCES afc22932-5f64-47bb-a2a1-171eab2537de | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2011 | second_quarter | MED | NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) America Invents Act HR1249 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA) | 160000 | 0 | 0 | 2011-07-08T14:42:06.707000-04:00 | |
| 1108724 | PARRY, ROMANI, DECONCINI & SYMMS 423624a8-f9f1-4bfe-90f4-2b03140f9aae | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2011 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T14:58:18.923000-04:00 | |
| 1108727 | PARRY, ROMANI, DECONCINI & SYMMS ac918148-70ff-4dce-b41f-a654227b3c41 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2011 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2011-07-08T15:08:20.700000-04:00 | |
| 1108746 | PARRY, ROMANI, DECONCINI & SYMMS 325761ad-b210-4806-867e-96a937079b48 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2011 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T15:35:33.777000-04:00 | |
| 1108787 | PARRY, ROMANI, DECONCINI & SYMMS ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2011 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T16:03:55.353000-04:00 | |
| 1108799 | PARRY, ROMANI, DECONCINI & SYMMS 1b4a13f8-f463-4395-b024-66054c7fc74a | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2011 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T16:16:02.027000-04:00 | |
| 1108851 | UNIVERSITY OF IOWA e64a6183-f2c1-4dc3-82c4-70f8c3e531c5 | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2011 | second_quarter | MED | FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2011-07-08T16:38:20.290000-04:00 | |
| 1108915 | BEN BARNES GROUP LP 37838855-a51e-4e34-a621-32ddaefe6276 | Q2 | BEN BARNES GROUP LP | 5415 | HUNTSMAN CANCER INSTITUTE | 2011 | second_quarter | MED | Medical research | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2011-07-10T11:20:23.193000-04:00 | |
| 1108924 | BEN BARNES GROUP LP 76a700ba-beb3-4423-87d1-2f8d3282ee88 | Q2 | BEN BARNES GROUP LP | 5415 | OKLAHOMA RESEARCH MEDICAL FOUNDATION | 2011 | second_quarter | MED | Medical research | SENATE | 20100 | 0 | 0 | 2011-07-10T12:02:28.300000-04:00 | |
| 1108983 | PAW AND ASSOCIATES a99ec091-ab61-4626-8872-a50e3e4805af | Q2 | PAW AND ASSOCIATES | 74875 | SCOTTSDALE HEALTHCARE | 2011 | second_quarter | MED | Educate officials on the capabilities to respond to local, regional and natural disasters using a military partnership as a cornerstone | Air Force, Dept of,Army, Dept of (Other),Defense, Dept of (DOD),Natl Guard | 10000 | 0 | 0 | 2011-07-10T14:30:07.687000-04:00 | |
| 1109070 | HOLLAND & KNIGHT LLP f2ce45fe-2461-4591-9db2-f86c7edcd1e5 | Q2 | HOLLAND & KNIGHT LLP | 18466 | SHIRE PHARMACEUTICALS, INC | 2011 | second_quarter | MED | Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-11T11:18:04.190000-04:00 | |
| 1109131 | HOLLAND & KNIGHT LLP e3716adb-e53e-4d18-b5fd-b2ce6ad324fe | Q2 | HOLLAND & KNIGHT LLP | 18466 | ALLIANCE FOR REGENERATIVE MEDICINE | 2011 | second_quarter | MED | Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE | 80000 | 0 | 0 | 2011-07-11T11:49:36.593000-04:00 | |
| 1109169 | HOLLAND & KNIGHT LLP 317a6159-365e-446d-82e7-6d42ed02022e | 2T | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2011 | second_quarter | MED | Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 1 | 2011-07-11T12:02:58.890000-04:00 | |
| 1109193 | HOLLAND & KNIGHT LLP 6a9d74ff-c691-4d13-9e68-af110e2ca8cb | 2T | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2011 | second_quarter | MED | Biomedical Research; CDC Hemophilia program; HRSA Hemophilia Program | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40000 | 0 | 1 | 2011-07-11T12:08:08.093000-04:00 | |
| 1109206 | HOLLAND & KNIGHT LLP 1ed1c57b-d601-4451-8f83-4ffaa9f08658 | 2T | HOLLAND & KNIGHT LLP | 18466 | AABB | 2011 | second_quarter | MED | Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2011-07-11T12:14:15.407000-04:00 | |
| 1109368 | HAAKE & ASSOCIATES d69e0327-99ec-400e-956f-bc302a4092dd | Q2 | HAAKE & ASSOCIATES | 17226 | CRUCELL SWITZERLAND AG | 2011 | second_quarter | MED | Work on authorization/ approval, appropriations, and policy matters regarding vaccines. | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) | 20000 | 0 | 0 | 2011-07-11T13:52:42.590000-04:00 | |
| 1109465 | AMERICAN COLLEGE OF CLINICAL PHARMACY c604db59-9568-432b-91bb-b3e54d544075 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2011 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59600 | 0 | 0 | 2011-07-11T14:57:37.943000-04:00 | |
| 1109468 | HAAKE & ASSOCIATES 1e6854b1-d7e4-4d87-97b5-2a98d804a611 | Q2 | HAAKE & ASSOCIATES | 17226 | MEDINSTILL, INC. | 2011 | second_quarter | MED | Medical device approval and policy matters. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-11T15:03:40.443000-04:00 | |
| 1109506 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY e381a45d-2c31-407a-96a5-2110e46f1398 | Q2 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2011 | second_quarter | MED | Appropriations for Federal Health Agencies Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortag Regulation of Laboratory Developed Tests; Debt Ceiling Negotiations | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE | 61000 | 0 | 0 | 2011-07-11T15:56:07.547000-04:00 | |
| 1109780 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7fc1ddb0-6cbf-4eb4-a946-98377eca84c9 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2011 | second_quarter | MED | No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2011-07-12T10:11:43.047000-04:00 | |
| 1109789 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 89ca5832-74a2-441e-b150-cfecf3e7d258 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | SAGE PUBLICATIONS, INC. | 2011 | second_quarter | MED | No Bill#, Federal Research Public Access Act National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-12T10:14:45.810000-04:00 | |
| 1109809 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 338d276b-c981-4d01-96b5-ae17b5e7b9e7 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2011 | second_quarter | MED | No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research Continuing Resolutions, FY 2011 HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-12T10:25:53.357000-04:00 | |
| 1109827 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f671a304-551e-4254-b390-d3f9582b8567 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION | 2011 | second_quarter | MED | No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011 | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2011-07-12T10:34:00.373000-04:00 | |
| 1109862 | SQUIRE PATTON BOGGS 44620133-9cf6-4e9e-abe3-04edad41932b | Q2 | SQUIRE PATTON BOGGS | 30906 | GENENTECH, INC. | 2011 | second_quarter | MED | Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process. Support for legislation preserving patient and physician choice in medical treatments. PATIENTS Act (S.660) | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2011-07-12T10:40:13.437000-04:00 | |
| 1109897 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e82b578f-4fc9-487a-86b5-3338a8857d90 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | COOLEY'S ANEMIA FOUNDATION | 2011 | second_quarter | MED | Drug review and approval process | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-12T10:52:33.950000-04:00 | |
| 1109961 | HEALTHFUTURES, LLC fca49cc1-cebf-4678-86eb-13e2933ccb03 | 2T | HEALTHFUTURES, LLC | 400359646 | TETHYS BIOSCIENCE | 2011 | second_quarter | MED | Regulation of laboratory developed tests. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2011-07-12T11:23:09.527000-04:00 | |
| 1109984 | HEALTHFUTURES, LLC 1468d393-c529-4d82-a273-a5da1a227a3f | 2T | HEALTHFUTURES, LLC | 400359646 | NAVIGENICS, INC. | 2011 | second_quarter | MED | Oversight and regulation of genetic testing Direct to consumer genetic testing | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2011-07-12T11:26:18.057000-04:00 | |
| 1110134 | HEALTHFUTURES, LLC 0ff748d3-cd58-4b0f-92f7-bc605334d361 | 2T | HEALTHFUTURES, LLC | 400359646 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2011 | second_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, American Invents Act | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 30000 | 0 | 1 | 2011-07-12T13:46:55.473000-04:00 | |
| 1110148 | HEALTHFUTURES, LLC 69aa4e86-2534-4e83-b839-bc6da99ec508 | 2T | HEALTHFUTURES, LLC | 400359646 | LIFE TECHNOLOGIES | 2011 | second_quarter | MED | No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 1 | 2011-07-12T14:03:08.113000-04:00 | |
| 1110169 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4a94d196-6327-4f15-8310-3b7cb185db8f | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ONYX PHARMACEUTICALS | 2011 | second_quarter | MED | Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-12T14:13:21.830000-04:00 | |
| 1110318 | DALRYMPLE & ASSOCIATES, LLC 07313929-b4d6-489e-b26c-01c69947964f | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2011 | second_quarter | MED | Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2011-07-12T15:25:56.157000-04:00 | |
| 1110348 | DALRYMPLE & ASSOCIATES, LLC 91537c50-e396-4e75-81cc-7562e3121d24 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | SANOFI PASTEUR | 2011 | second_quarter | MED | Vaccine research and development legislation, funding, appropriations and oversight. | Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office | 46000 | 0 | 0 | 2011-07-12T15:35:13.267000-04:00 | |
| 1110618 | RAY C CULVER III 4341372b-5cc4-443a-b25c-f61eb00c5a5c | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2011 | second_quarter | MED | Funding for ARS Human Nutrition Centers in HR 2112, FY12 Agricultural Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-12T21:19:45.993000-04:00 | |
| 1110949 | SRI INTERNATIONAL c1ebdf42-754a-4953-9dab-9f53c27bb8fb | Q2 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2011 | second_quarter | MED | FY12 House Defense Appropriations (HR 2219) FY12 House and Senate Defense Authorizations (HR 1540/S 1253) | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2011-07-13T10:55:57.027000-04:00 | |
| 1111242 | ASSN OF MEDICAL DEVICE REPROCESSORS aa926d53-c387-4687-8534-4255d0659e89 | Q2 | ASSN OF MEDICAL DEVICE REPROCESSORS | 291732 | ASSN OF MEDICAL DEVICE REPROCESSORS | 2011 | second_quarter | MED | Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-13T13:25:54.373000-04:00 | |
| 1111379 | DALRYMPLE & ASSOCIATES, LLC b0d8de59-60e5-47eb-9dde-66bd0e0cdc8a | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | DISCOVERY LABORATORIES | 2011 | second_quarter | MED | Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 5000 | 0 | 0 | 2011-07-13T14:36:04.327000-04:00 | |
| 1111436 | DALRYMPLE & ASSOCIATES, LLC 8de26d35-41f1-47ae-b21d-62a240e58a54 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | BRIGHTON BIOTECH, INC. | 2011 | second_quarter | MED | Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 15000 | 0 | 0 | 2011-07-13T14:49:33.590000-04:00 | |
| 1111468 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 1c964f4a-03df-42d8-9deb-b7b59790587e | Q2 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2011 | second_quarter | MED | No bill #: Advocate for disability and rehabilitation prioirities of the Patient Centered Outcomes Research Institute, espcially regarding comparative effectiveness research. Advocate for elevation of the National Center for Medical Rehabilitation Research within the National Institutes of Health. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 120000 | 0 | 0 | 2011-07-13T14:54:44.530000-04:00 | |
| 1111495 | BEN BARNES GROUP LP 102ab634-41e8-437d-b46b-2a5225765502 | Q2 | BEN BARNES GROUP LP | 5415 | FAIR LABORATORY PRACTICES ASSOCIATION | 2011 | second_quarter | MED | Bring attention to prevention of unfair billing practices by laboratories for Medicare services | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-13T15:04:59.873000-04:00 | ||
| 1112097 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 37d99904-bebe-4d58-874f-6af042d91f2f | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | PATH | 2011 | second_quarter | MED | Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-14T10:48:21.030000-04:00 | |
| 1113156 | BOB MOSS ASSOCIATES 30292a6d-e7f1-4375-b711-abff79557875 | 2T | BOB MOSS ASSOCIATES | 51877 | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH) | 2011 | second_quarter | MED | Sewcuring continued support from Congress for Sanford Burnham's medical research p[rograms. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 1 | 2011-07-14T17:38:35.967000-04:00 | |
| 1113285 | CHILDREN'S HOSPITAL BOSTON 4d1564bb-5b76-4f3a-9175-9c09220b07b3 | Q2 | CHILDREN'S HOSPITAL BOSTON | 9066 | CHILDREN'S HOSPITAL BOSTON | 2011 | second_quarter | MED | Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2011-07-15T08:06:53.987000-04:00 | |
| 1113323 | MEHLMAN CONSULTING, INC. df2deb25-985a-4b98-a69f-358adb73dbb0 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | NATIONAL VENTURE CAPITAL ASSOCIATION | 2011 | second_quarter | MED | FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) | HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 60000 | 0 | 0 | 2011-07-15T08:54:13.440000-04:00 | |
| 1113404 | WEBMD HEALTH CORP. 51dd346e-361b-4b2b-a64d-716ab0310b7c | Q2 | WEBMD HEALTH CORP. | 55473 | WEBMD HEALTH CORP | 2011 | second_quarter | MED | Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records. | SENATE | 40000 | 0 | 0 | 2011-07-15T09:27:43.157000-04:00 | |
| 1113653 | LIFE TECHNOLOGIES CORPORATION f2085cd1-fd5f-4144-aaf3-f27a0689e629 | Q2 | LIFE TECHNOLOGIES CORPORATION | 400391833 | LIFE TECHNOLOGIES CORPORATION | 2011 | second_quarter | MED | BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. | HOUSE OF REPRESENTATIVES,SENATE | 210000 | 0 | 0 | 2011-07-15T11:18:02.533000-04:00 | |
| 1113957 | THE CORMAC GROUP, LLC 8d835861-f42c-4def-9edb-b5ccb43bf972 | Q2 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2011 | second_quarter | MED | Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-15T12:23:48.207000-04:00 | |
| 1114519 | GENENTECH, INC c0acace8-c62f-489c-b8d4-47049f65432c | Q2 | GENENTECH, INC | 15920 | GENENTECH INC | 2011 | second_quarter | MED | Public Law 111-148, the Patient Protection and Affordable Care Act of 2009 - Implementation issues related to the authorization for comparatice effective research and the Patient-Centered Outcomes Research Institute. | HOUSE OF REPRESENTATIVES,SENATE | 1140295 | 0 | 0 | 2011-07-15T15:29:33.307000-04:00 | |
| 1114576 | CEPHEID 37a1d51e-33c8-47fc-b7e7-ccfd9191f932 | Q2 | CEPHEID | 400270233 | CEPHEID | 2011 | second_quarter | MED | See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011 HR 2182 Generating Antibiotic Incentives Now (GAIN) S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-07-15T15:47:01.777000-04:00 | |
| 1114614 | PERSONALIZED MEDICINE COALITION da6e457e-a304-4c5c-a6d9-c39e5e657543 | Q2 | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2011 | second_quarter | MED | CER, CMS, Coverage of Genetic Testing | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 68403 | 0 | 0 | 2011-07-15T16:11:19.150000-04:00 | |
| 1114632 | PERSONALIZED MEDICINE COALITION 8f5e5a43-48c5-4d71-a881-34a25de32fe8 | 2A | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2011 | second_quarter | MED | CER, CMS, Coverage of Genetic Testing | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 6403 | 0 | 0 | 2011-07-15T16:17:32.027000-04:00 | |
| 1114955 | THE HARRIS FIRM 9f187d41-61b0-4213-aead-0d909e211dba | Q2 | THE HARRIS FIRM | 68376 | DIRECT MESSAGE LAB | 2011 | second_quarter | MED | Regarding funding for FY 11 pertaining to software communication system for chronic disease management | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-15T18:50:15.697000-04:00 | ||
| 1115008 | DANIELLE ORGAN PETERS 4f75d6e9-5d17-40f9-be92-f51c79e62ac8 | Q2 | DANIELLE ORGAN PETERS | 400427062 | FABIANI & COMPANY ON BEHALF OF NANOTHERAPEUTICS INC. | 2011 | second_quarter | MED | Funding for flexible manufacturing to address public health emergencies | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-16T06:52:58.800000-04:00 | ||
| 1115241 | THE PETRIZZO GROUP, INC. 69a297c2-56dd-45e2-bf26-84fc81c5a36f | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2011 | second_quarter | MED | Advocated for legislativion to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-16T20:49:23.977000-04:00 | |
| 1115244 | THE PETRIZZO GROUP, INC. 79061dfc-3ffb-49ae-852e-305b282edf7c | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE BIOMEDICAL RESEARCH INSTITUTE | 2011 | second_quarter | MED | Advocate for funding to support next - generation drug development for Leishmaniasis. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-16T20:54:24.977000-04:00 | |
| 1115250 | THE PETRIZZO GROUP, INC. 61d6c95d-7da7-4461-be02-45bb558d3893 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CANCER CARE ALLIANCE | 2011 | second_quarter | MED | Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-16T21:00:25.913000-04:00 | |
| 1115252 | THE PETRIZZO GROUP, INC. 00966db2-9c1d-48f3-9c57-189c778678d2 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SAGE THERAPEUTICS, INC. | 2011 | second_quarter | MED | Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-16T21:11:26.897000-04:00 | |
| 1115392 | W STRATEGIES, LLC 4b7319f5-0af1-447a-95a3-108d17f095a2 | Q2 | W STRATEGIES, LLC | 400605842 | 23ANDME, INC. | 2011 | second_quarter | MED | Issues relating to FDA regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-17T13:28:04.440000-04:00 | |
| 1115792 | VAN SCOYOC ASSOCIATES b6d16617-666d-4571-9237-afc1606ae8f2 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | MEDICINES FOR MALARIA VENTURE | 2011 | second_quarter | MED | USAID and Malaria research and development issues and initiatives | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID) | 30000 | 0 | 0 | 2011-07-18T05:44:00.197000-04:00 | |
| 1115794 | VAN SCOYOC ASSOCIATES 6af8d8be-ee2e-47b4-bdfe-2af9c12f2758 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | CUREMARK LLC | 2011 | second_quarter | MED | Therapeutic treatment for autism issues generally. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-07-18T05:52:01.293000-04:00 | |
| 1116302 | WHITMER & WORRALL, LLC ee7ec830-a9c5-4cb2-8338-cfa74b76298f | Q2 | WHITMER & WORRALL, LLC | 292892 | NEURO KINETICS | 2011 | second_quarter | MED | Issues related to Traumatic Brain Injury (TBI). | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-18T10:06:57.527000-04:00 | |
| 1116310 | POLICY DIRECTIONS INC. b8f1f628-d97f-4ee9-8743-a7d251cedc2b | 2T | POLICY DIRECTIONS INC. | 31747 | ADVANCED LIFE SCIENCES | 2011 | second_quarter | MED | FDA regulatory pathway for new antibiotic medicines. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-07-18T10:06:59.290000-04:00 | ||
| 1116388 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS ada10fb9-6a1f-4253-8d11-a9c07f16c7b0 | Q2 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 1375 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2011 | second_quarter | MED | Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 157926 | 0 | 0 | 2011-07-18T10:20:46.260000-04:00 | |
| 1116941 | POLICY DIRECTIONS INC. 880e57a5-4c98-4c08-ba11-b803e4594f36 | Q2 | POLICY DIRECTIONS INC. | 31747 | VITAPATH GENETICS, INC. | 2011 | second_quarter | MED | New regulatory requirements for diagnostics. Seeking federal funding for novel genetic diagnostic tests. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T11:29:51.853000-04:00 | |
| 1116973 | KSCW, INC. 48c1617e-a380-4191-bfe2-919532abbae1 | Q2 | KSCW, INC. | 21596 | INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS | 2011 | second_quarter | MED | Legislation and regulation affecting the Medical device industry | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-18T11:35:10.320000-04:00 | |
| 1117201 | MEHLMAN CONSULTING, INC. eeaa21ba-f73d-4da3-90bf-4a781c329efc | Q2 | MEHLMAN CONSULTING, INC. | 284950 | MAYO CLINIC | 2011 | second_quarter | MED | NIH appropriations | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-18T12:30:08.710000-04:00 | |
| 1117259 | POLICY DIRECTIONS INC. 9f2af335-4f90-499a-ba2e-22a5789b4bc7 | Q2 | POLICY DIRECTIONS INC. | 31747 | BAYLOR COLLEGE OF MEDICINE | 2011 | second_quarter | MED | S. 606 - Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-18T12:47:37.383000-04:00 | |
| 1117603 | TURNER & GOSS LLP 7229c5f4-ef39-4b0c-853c-9d691f205513 | Q2 | TURNER & GOSS LLP | 316310 | CYSTIC FIBROSIS FOUNDATION | 2011 | second_quarter | MED | Reauthorization of Prescription Drug User Fee Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-18T13:43:27.977000-04:00 | ||
| 1117663 | PARALYZED VETERANS OF AMERICA 73b73c8c-3933-4be4-b022-0d0781b69379 | Q2 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2011 | second_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 86931 | 0 | 0 | 2011-07-18T13:54:55.477000-04:00 | |
| 1117969 | GROUP HEALTH COOPERATIVE 76b00ce5-dc09-418d-8e7a-5df8f969fc65 | Q2 | GROUP HEALTH COOPERATIVE | 17022 | GROUP HEALTH COOPERATIVE | 2011 | second_quarter | MED | Issues related to health reform legislation and regulation including Medicare Advantage; insurance regulation changes; insurance taxes; health cooperatives; health systems reserach topics such as the patient-centered medical home; the Patient Protection and Affordable Care Act. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office | 110000 | 0 | 0 | 2011-07-18T14:33:27.473000-04:00 | |
| 1118122 | NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 1b066560-b869-4bee-a46e-f15ed475fd4a | Q2 | NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE | 48975 | NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE | 2011 | second_quarter | MED | Reduce health care disparities in service and in research. Support the Minority AIDS initiative. | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Federal Bureau of Investigation (FBI),Federal Communications Commission (FCC),Federal Deposit Insurance Corporation (FDIC),Federal Emergency Management Agency (FEMA),Federal Reserve System,Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Park Service (NPS),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Office of Thrift Supervision (OTS),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Commission on Civil Rights,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA),Voice of America,White House Office | 50000 | 0 | 0 | 2011-07-18T14:55:52.317000-04:00 | |
| 1118272 | THE OUTLAW GROUP 2277dbd7-840f-4c57-9790-46f045a3a3f0 | Q2 | THE OUTLAW GROUP | 46095 | AMERICAN TINNITUS ASSOCIATION | 2011 | second_quarter | MED | Legislation to increase federal support for research aimed at preventing, treating and curing tinnitus. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T15:09:01.643000-04:00 | |
| 1118299 | DENNY MILLER ASSOCIATES a14a9d46-47f7-447c-b62c-de8764ccb6e4 | Q2 | DENNY MILLER ASSOCIATES | 25328 | SABEY CORPORATION | 2011 | second_quarter | MED | Oversight and implementation of the Patient Protection and Affordable Care Act (Public Law 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal grant funding through the National Institutes of Health. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-18T15:13:15.787000-04:00 | |
| 1118424 | DENNY MILLER ASSOCIATES 233a33ba-6abe-4d8c-b18b-f6e8056f82c2 | Q2 | DENNY MILLER ASSOCIATES | 25328 | ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER | 2011 | second_quarter | MED | Labor, Health and Human Services, Education Appropriations Bill, 2012, provisions relating to rural health care. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T15:31:21.317000-04:00 | |
| 1118581 | OGR 7c862f24-c798-4396-8828-ddb69ace00f8 | Q2 | OGR | 48827 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2011 | second_quarter | MED | Issues related to insuring access to over-the-counter drugs. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-18T16:03:53.317000-04:00 | |
| 1118707 | LATHAM & WATKINS LLP ae7a0385-3a0d-485f-8220-5eaff4957988 | Q2 | LATHAM & WATKINS LLP | 22201 | BOSTON SCIENTIFIC CORPORATION | 2011 | second_quarter | MED | Congressional oversight of the Food and Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-18T16:33:02.427000-04:00 | |
| 1119136 | FIRST STRATEGIC 30f7f61a-c66d-4d19-b491-af4215c897f1 | Q2 | FIRST STRATEGIC | 91091 | PHOENIX CHILDREN'S HOSPITAL | 2011 | second_quarter | MED | Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-18T18:58:36.063000-04:00 | |
| 1119213 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 4f80b05d-c0b6-4122-9c88-15a4e3bff806 | Q2 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | ABBOTT LABORATORIES | 2011 | second_quarter | MED | Healthcare reform Legal reform Theft of medical products | 60000 | 0 | 0 | 2011-07-18T19:59:14.093000-04:00 | ||
| 1119218 | THE PETRIZZO GROUP, INC. a93ed7ac-2cc1-4092-a065-d0fda86ec53d | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2011 | second_quarter | MED | Advocated for federal funding for the Allen Institute Human Brain Atlas Project, which will create a comprehensive 3-dimensional map detailing gene expression in the human brain. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T20:06:15.690000-04:00 | |
| 1119219 | THE PETRIZZO GROUP, INC. e8a2e0bc-c178-40d7-aec5-5d247a49a881 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2011 | second_quarter | MED | Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T20:10:16.533000-04:00 | |
| 1119225 | THE PETRIZZO GROUP, INC. 56bb2b4c-5770-4f00-baae-29f51d17af19 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | FATE THERAPEUTICS, INC. | 2011 | second_quarter | MED | Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. | Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T20:12:18.380000-04:00 | |
| 1119229 | FIRST STRATEGIC d98becf6-7356-4292-a34f-046a3a8fe011 | Q2 | FIRST STRATEGIC | 91091 | TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | 2011 | second_quarter | MED | The Creating Hope Act - issues regarding drug development for pediatric rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-18T20:15:19.290000-04:00 | |
| 1119360 | PHOENIX CHILDREN'S HOSPITAL 1334f275-7964-4963-b583-965a5721b693 | Q2 | PHOENIX CHILDREN'S HOSPITAL | 400381743 | PHOENIX CHILDREN'S HOSPITAL | 2011 | second_quarter | MED | Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-18T21:57:28.027000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);